Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Sun Pharma, Rockwell Medical ink licensing pact for Triferic in IndiaSun Pharma, Rockwell Medical ink licensing pact for Triferic in India
    CDSCO declares 450 FDCs as rational, issues directions for manufacturersCDSCO declares 450 FDCs as rational, issues directions for manufacturers
    Former BDM, others arrested for stealing data from pharma firmFormer BDM, others arrested for stealing data from pharma firm
    Alembic Pharma gets USFDA nod for spasticity drug TizanidineAlembic Pharma gets USFDA nod for spasticity drug Tizanidine
    SEBI exempts Trust from making open offers for Torrent Group CompaniesSEBI exempts Trust from making open offers for Torrent Group Companies
    USFDA panel votes against Nektar painkillerUSFDA panel votes against Nektar painkiller
    Drug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; DetailsDrug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; Details
    Lupin Tarapur facility cautioned by USFDA post inspectionLupin Tarapur facility cautioned by USFDA post inspection
    Alembic Pharma gets USFDA nod for depression drug Vilazodone Hydrochloride tabletsAlembic Pharma gets USFDA nod for depression drug Vilazodone Hydrochloride tablets
    Biogen to buy Alzheimers, Parkinsons treatment from Pfizer for USD 75 millionBiogen to buy Alzheimers, Parkinsons treatment from Pfizer for USD 75 million
    AstraZeneca to end heart drug Epanova trial, expects USD 100 million writedownAstraZeneca to end heart drug Epanova trial, expects USD 100 million writedown
    Pharma firm founder, former employees face reckoning in opioid bribery casePharma firm founder, former employees face reckoning in opioid bribery case
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok